Market Rally: Top TSX Cannabis Stocks for June 2020

Some of the top TSX cannabis stocks have seen a consistent surge in the last few months. Do you own these in your portfolio?

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

After a steep decline in 2019, cannabis investors expected the industry to see some better days this year. While there is a whole new set of challenges this year, some optimism is certainly visible for a few TSX cannabis stocks.

TSX cannabis stocks as a whole have lost around 10% so far this year. The lockdowns and stay-at-home orders worked in pot companies’ favour, resulting in higher revenues last quarter.

However, dwindling revenues amid increasing competition and a liquidity crunch have crushed many cannabis players in the recent past. To add to the woes, some fundamental challenges, like the slower roll-out of retail stores and the expansion of the black market, continue to dominate.

TSX cannabis stock that stole the focus

Aurora Cannabis (TSX:ACB)(NYSE:ACB) is one pot stock that recently stole the limelight. First, for its price, which has more than doubled since its reverse-stock-split earlier this month. And second, for its volatility. Cannabis stocks are some of the most volatile sections of the broader markets. However, Aurora stock was even more volatile this month.

Its better-than-expected quarterly earnings, acquisition of Reliva, and potential turnaround contributed to investors’ optimism. However, how all these factors play out in the next couple of quarters will be interesting to see.

Interestingly, Aurora’s entry into the U.S. cannabidiol (CBD) market with Reliva could open a new growth path for it. However, an acquisition that already has a big pile of debt, together with the U.S. FDA’s stance regarding the CBD market, are some of the factors worth pondering.

Aphria: Profitable, well-capitalized

Aphria (TSX:APHA)(NYSE:APHA) seems relatively well-placed on the liquidity and profitability fronts. In terms of financials, Aphria is ahead in the race, with linking quarters of profits. Investors should note that there are many marijuana companies at the moment that are not expected to report profits for the next several quarters.

Also, Aphria’s flourishing presence in Europe could be its growth engine for the next few years. A favourable cash position and growth prospects in the cannabis derivatives markets make Aphria an exciting bet.

Aphria stock has fallen only marginally so far this year, beating the TSX stocks at large, which has lost approximately 10%.

The biggest of the TSX cannabis stocks

Speaking of cash-rich marijuana companies, let’s not forget Canopy Growth (TSX:WEED)(NYSE:CGC). Canopy is the biggest among pot stock by market cap. Even though the company has been burning significant cash in the last few quarters, its cash and equivalents were strong at $2.5 billion as of December 31, 2019.

It will report fourth-quarter earnings on May 29. Apart from its revenue and earnings figure, its cash burn rate will decide the stock’s path ahead. Notably, Canopy Growth stock has largely followed peers, doubling since the epic sell-off in March.

Foolish bottom line

From a valuation standpoint, Aurora is trading at a price-to-sales multiple of 8 times, Aphria is close to 3 times, and Canopy is expensive at 21 times. Apart from the attractive valuation, Aphria’s strong cash position will be more comforting to investors. Clearly, it is a comparatively safe bet in a risky industry.

Many top TSX cannabis stocks have seen a consistent surge in the last few months. However, that should not be seen as the next bull rally. Some significant challenges remain for them, and stocks will continue to remain highly volatile. It remains a high-risk, high-reward game for investors and certainly not for the faint-hearted.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vineet Kulkarni has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »